Loss of RelA/p65 in human NSCLC cells resulted in the upregulation of CD82/KAI1 (Figure 3A) and the downregulation of ROS1 proto-oncogene (Figure 3B) mRNA levels. The gene discussed is CD82; the disease is non-small cell lung carcinoma.